| Tlc | |
|
5641 Audrey Ave, Inver Grove Heights, MN 55077-1812 | |
| (612) 554-5005 | |
| Not Available |
| Full Name | Tlc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 5641 Audrey Ave, Inver Grove Heights, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336404821 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 101152 (Minnesota) | Secondary |
| 235Z00000X | Speech-language Pathologist | 5742 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tlc 6311 Wayzata Blvd, Suite 310, Minneapolis, MN 55416-1209 Ph: (952) 545-0200 | Tlc 5641 Audrey Ave, Inver Grove Heights, MN 55077-1812 Ph: (612) 554-5005 |
News Archive
The recent US Food and Drug Administration (FDA) approval of aducanumab – which has the potential to treat Alzheimer's disease – may provide a proof of concept that can be rapidly improved upon, writes Dennis Selkoe in this Perspective.
Late stage pancreatic cancer benefits from photodynamic therapy (PDT) but the resources needed for the usual accompanying dosimetry present barriers, Dartmouth researchers Jonathan T. Elliott, PhD and Brian C. Pogue, PhD have mitigated by using common clinical technologies.
Chronic constipation affects 15 to 20 percent of the U.S. population. Nearly one-third of affected people have dyssynergic defecation, in which muscles used for bowel movements do not work well, but there's some good news.
Hokkaido University and Hitachi, Ltd. have announced that the approval under Japan's Pharmaceutical Affairs Law has been granted to Hitachi for the manufacture and sales of the PROBEAT-RT, a proton beam therapy treatment system combining spot scanning irradiation and Real-time Tumor-tracking Radiation Therapy.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.
› Verified 5 days ago
Rachel Lynn Kuenzli, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2925 Buckley Way, Inver Grove Heights, MN 55076 Phone: 651-455-0561 | |
Heidi Kutz, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2925 Buckley Way, Inver Grove Heights, MN 55076 Phone: 651-455-0561 | |
Inga Sveen, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2925 Buckley Way, Inver Grove Heights, MN 55076 Phone: 651-455-0561 | |
Mrs. Julie Rae Skokan, MACCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5842 Blackshire Path, Suite 201, Inver Grove Heights, MN 55076 Phone: 651-554-9940 Fax: 651-554-9941 | |
Kortney Benzie, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2925 Buckley Way, Inver Grove Heights, MN 55076 Phone: 654-455-0561 | |
Andrew Schlichting, M.A. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1301 50th St E, Inver Grove Heights, MN 55077 Phone: 651-451-1853 | |
Eva Buchmayer, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2925 Buckley Way, Inver Grove Heights, MN 55076 Phone: 651-455-0561 Fax: 651-457-4401 |